Šamadan, L., Papić, N., Mijić, M., Knežević Štromar, I., Gašparov, S. & Vince, A. (2022). Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?. Biomedicines, 10. (12). doi: 10.3390/biomedicines10123014
Šamadan, Lara, et al. "Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?." Biomedicines, vol. 10, no. 12, 2022. https://doi.org/10.3390/biomedicines10123014
Šamadan, Lara, Neven Papić, Maja Mijić, Ivana Knežević Štromar, Slavko Gašparov and Adriana Vince. "Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?." Biomedicines 10, no. 12 (2022). https://doi.org/10.3390/biomedicines10123014
Šamadan, L., et al. (2022) 'Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?', Biomedicines, 10(12). doi: 10.3390/biomedicines10123014
Šamadan L, Papić N, Mijić M, Knežević Štromar I, Gašparov S, Vince A. Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?. Biomedicines [Internet]. 2022 November 23 [cited 2024 August 16];10(12). doi: 10.3390/biomedicines10123014
L. Šamadan, N. Papić, M. Mijić, I. Knežević Štromar, S. Gašparov and A. Vince, "Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?", Biomedicines, vol. 10, no. 12, November 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:444120. [Accessed: 16 August 2024]